Oral washes and tongue swabs for Xpert MTB/RIF Ultra-based tuberculosis diagnosis in people with and without the ability to make sputum
Authors:
Preprint
- 18 March 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: Oral samples show promise for tuberculosis (TB) diagnosis. Data from different samples and people with sputum scarce TB are limited. Methods: We assessed Xpert MTB/RIF Ultra (Ultra) in symptomatic people at clinics (Cohort A, n=891) or at antiretroviral therapy (ART)-initiation without syndromic preselection (Cohort B, n=258). In Cohort A, we collected oral washes (OWs) and, separately, tongue swabs (flocked, foam with heat). In Cohort B, we collected OWs, three flocked tongue swabs (comparing one with heat to two pooled swabs) and, separately, buccal swabs, periodontal brushes. We offered sputum induction and did different culture methods on a subset of Cohort B tongue swabs. Results: In Cohort A, Ultra on OWs, flocked tongue and foam swabs had sensitivities of 80% (95% confidence interval 56, 94), 59% (53, 65) and 65% (58, 72) and high specificities. In Cohort B, OWs and single heated swabs had 71% (42, 92) and 64% (35, 87) sensitivity, respectively. Pooled tongue swabs, buccal swabs and periodontal brushes had low sensitivities. MGIT960 had the highest sensitivity [64% (35, 87)] of culture methods. Oral sampling detected TB in sputum-scarce people [Cohort A: 25% (7/28) flocked and foam swab-positive; Cohort B: 18% (10/56) OW-, 23% (13/56) single flocked swab-positive]. In Cohort B, this would at least double the people with a positive Ultra result (sputum or oral) if induction were unavailable. Conclusion: Ultra on OWs or foam tongue swabs has higher sensitivity than other oral-based approaches and detects sputum-scarce TB, resulted in more people diagnosed compared to Ultra on expectorated sputum.Keywords
All Related Versions
This publication has 28 references indexed in Scilit:
- Trade-offs between clinical performance and test accessibility in tuberculosis diagnosis: a multi-country modelling approach for target product profile developmentThe Lancet Global Health, 2024
- Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future researchThe Lancet Global Health, 2024
- Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy studyThe Lancet Global Health, 2024
- Blood RNA biomarkers for tuberculosis screening in people living with HIV before antiretroviral therapy initiation: a diagnostic accuracy studyThe Lancet Global Health, 2024
- Oral swabs with a rapid molecular diagnostic test for pulmonary tuberculosis in adults and children: a systematic reviewThe Lancet Global Health, 2023
- Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection: a diagnostic accuracy evaluationThe Lancet Microbe, 2023
- Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy studyThe Lancet Respiratory Medicine, 2020
- Microbiological diagnosis of pulmonary tuberculosis in children by oral swab polymerase chain reactionScientific Reports, 2019
- Polymerase Chain Reaction ofsecA1on Sputum or Oral Wash Samples for the Diagnosis of Pulmonary TuberculosisClinical Infectious Diseases, 2009
- Identification of M. tuberculosis ribosomal RNA in mouthwash samples from patients with tuberculosisRespiratory Medicine, 1994